VISIT | Baseline | Intervention** (for 12 weeks) | Week 12 | Week 24 Follow up | Week 48 Follow up |
---|---|---|---|---|---|
Time (months) | -1 | 0 | 1 – 3 | 6 | 12 |
Primary outcome measure | |||||
WOMAC-Pain | X | X | X | X | X |
Secondary outcome measures | |||||
WOMAC-Physical function | X | Â | X | X | X |
WOMAC-Stiffness | X | Â | X | X | X |
Physicians' Global KOA Severity | X | Â | X | X | X |
Patients' Global KOA Severity | X | Â | X | X | X |
SF-36 & EQ-5D & CES-D | X | Â | X | X | X |
Self-efficacy | X | Â | X | X | X |
Outcome Expectation | X | Â | X | X | X |
Social Support | X | Â | X | X | X |
Enjoyment Questionnaire | X | Â | X | X | X |
Physical Functional Tests*** | X | Â | X | X | X |
Physical Activity Questionnaire | X | Â | X | X | X |
Joint Proprioception | X | Â | X | X | X |
Medications | X | X | X | X | X |
Adverse Events | Â | X | X | X | X |
Body Mass Index | X | Â | X | X | X |
Weekly Update | Â | X | Â | Â | Â |
Knee X-Ray | X | Â | Â | Â | Â |
Adherence | Â | X | X | X | X |
Follow-up Questionnaire | Â | Â | Â | X | X |